Literature DB >> 22217975

Kingella endocarditis after closure of ventricular septal defect with a transcatheter device.

Imad Kassis, Yael Shachor-Meyouhas, Ihab Khatib, Asad Khoury, Trong Phi Le, Avraham Lorber.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22217975     DOI: 10.1097/INF.0b013e31823c3ec1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

Review 1.  Kingella kingae: carriage, transmission, and disease.

Authors:  Pablo Yagupsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Transcatheter Closure of Residual and Iatrogenic Ventricular Septal Defects: Tertiary Center Experience and Outcome.

Authors:  Fatma A Taha; Fareed Alnozha; Osama Amoudi; Mansour Almutairi; Reda Abuelatta
Journal:  Pediatr Cardiol       Date:  2021-09-08       Impact factor: 1.655

3.  Infective endocarditis following coil occlusion of perimembranous ventricular septal defect with the Nit-Occlud((®)) Le device.

Authors:  Amal M El-Sisi; Yasser M Menaissy; Samia A Bekheet
Journal:  Ann Pediatr Cardiol       Date:  2016 Jan-Apr

4.  Very late-onset endocarditis complicated by non-significant aortic regurgitation after device closure of perimembranous ventricular septal defect.

Authors:  Changqing Tang; Kaiyu Zhou; Yimin Hua; Chuan Wang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

5.  What is the best management option for non-significant residual shunt after device closure of perimembranous ventricular septal defect: A case report based on the lessons from post-procedure endocarditis.

Authors:  Shuran Shao; Chunyan Luo; Kaiyu Zhou; Yimin Hua; Chuan Wang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

6.  Long-term outcome of perimembranous VSD closure using the Nit-Occlud® Lê VSD coil system.

Authors:  Rainer Kozlik-Feldmann; Avraham Lorber; Horst Sievert; Peter Ewert; Christian Jux; Götz C Müller; Robert Dalla Pozza; Mustafa Yigitbasi; Dietmar Schranz; Angelika Lindinger; Omar Galal; Thomas Meinertz
Journal:  Clin Res Cardiol       Date:  2020-10-31       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.